Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2316892121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Natalie H Jones und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY 10065. Hauptthemen laut MEDLINE: Valosin Containing Protein. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS), National Science Foundation (NSF).
Abstract (Originalsprache)
The loss of function of AAA (ATPases associated with diverse cellular activities) mechanoenzymes has been linked to diseases, and small molecules that activate these proteins can be powerful tools to probe mechanisms and test therapeutic hypotheses. Unlike chemical inhibitors that can bind a single conformational state to block enzyme function, activator binding must be permissive to different conformational states needed for mechanochemistry. However, we do not know how AAA proteins can be activated by small molecules. Here, we focus on valosin-containing protein (VCP)/p97, an AAA unfoldase whose loss of function has been linked to protein aggregation-based disorders, to identify druggable sites for chemical activators. We identified VCP ATPase Activator 1 (VAA1), a compound that dose-dependently stimulates VCP ATPase activity up to ~threefold. Our cryo-EM studies resulted in structures (ranging from ~2.9 to 3.7 Å-resolution) of VCP in apo and ADP-bound states and revealed that VAA1 binds an allosteric pocket near the C-terminus in both states. Engineered mutations in the VAA1-binding site confer resistance to VAA1, and furthermore, modulate VCP activity. Mutation of a phenylalanine residue in the VCP C-terminal tail that can occupy the VAA1 binding site also stimulates ATPase activity, suggesting that VAA1 acts by mimicking this interaction. Together, our findings uncover a druggable allosteric site and a mechanism of enzyme regulation that can be tuned through small molecule mimicry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY 10065.
- Tri-Institutional PhD Program in Chemical Biology, New York, NY 10065.
- The David Rockefeller Graduate Program in Bioscience, The Rockefeller University, New York, NY 10065.
ORCID-Profile: Natalie H Jones, Noa E Dahan, Tarun M Kapoor
Förderung
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- National Science Foundation (NSF)
Zitieren
APA
Jones, N. H., Liu, Q., Urnavicius, L., Dahan, N. E., Vostal, L. E., & Kapoor, T. M. (2024). Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2316892121
Vancouver
Jones NH, Liu Q, Urnavicius L, Dahan NE, Vostal LE, Kapoor TM. Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2316892121
BibTeX
@article{Jones2024,
author = {Jones, Natalie H and Liu, Qiwen and Urnavicius, Linas and Dahan, Noa E and Vostal, Lauren E and Kapoor, Tarun M},
title = {Allosteric activation of VCP, an AAA unfoldase, by small molecule mimicry},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2316892121}
}
EUVIMED